» Articles » PMID: 18547417

Pancreatobiliary Versus Intestinal Histologic Type of Differentiation is an Independent Prognostic Factor in Resected Periampullary Adenocarcinoma

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2008 Jun 13
PMID 18547417
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Resectable adenocarcinomas in the pancreatic head, by definition "periampullary", originate from ampullary, duodenal, biliary, or ductal pancreatic epithelium. Typically, periampullary adenocarcinomas have either intestinal or pancreatobiliary type of differentiation, and the type of differentiation might be prognostically more important than the anatomic site of origin. The aim of the study was to determine whether the histologic type of differentiation is an independent prognostic factor in periampullary adenocarcinoma, and whether tumour origin predicts the prognosis in pancreatobiliary type carcinomas independently of resection margin involvement, tumour size, nodal involvement, perineural and vascular infiltration, and degree of differentiation.

Methods: Histopathologic variables in 114 consecutively resected periampullary adenocarcinomas of pancreatobiliary (n = 67) and intestinal (n = 47) type differentiation were evaluated using a standardized, systematic protocol for evaluation of the resected specimen (study group). Histologic type of differentiation and tumour origin were compared as predictors of survival, and the results were validated by comparison with a historical control group consisting of 99 consecutive pancreaticoduodenectomies performed before standardization of histopathologic evaluation. Associations between histopathologic variables were evaluated by Chi-square and Mann-Whitney tests. Survival was estimated by the Kaplan-Meier method, comparing curves using log-rank test, and by univariate and multivariable Cox regression analysis.

Results: Both in the study group (n = 114) and in the historical control group (n = 99), the histologic type of differentiation independently predicted survival, while tumour origin predicted survival only in univariate analysis. Independent adverse predictors of survival in the study group were pancreatobiliary type differentiation (p < 0.001; HR 3.1; CI 1.8-5.1), regional lymph node involvement (p < 0.001; HR 2.5; CI 1.5-4.4), vessel involvement (p = 0.012; HR 1.9; CI 1.2-3.1), and increasing tumour diameter (measured in cm, p = 0.011; HR 1.3; CI 1.1-1.5). For pancreatobiliary differentiated adenocarcinomas (n = 67), lymph node status, vessel involvement, and tumour diameter remained independent prognostic factors, while tumour origin did not independently predict the prognosis due to significant association with tumour size (p < 0.001) and lymph node involvement (p = 0.004).

Conclusion: Pancreatobiliary versus intestinal type of differentiation independently predicts poor prognosis after pancreaticoduodenectomy for periampullary adenocarcinoma. Lymph node involvement, vessel infiltration, and increasing tumour diameter are adverse predictors of survival in tumours with pancreatobiliary differentiation.

Citing Articles

Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type.

Rahnea-Nita G, Rebegea L, Grigorean V, Coman I, Coman V, Plesea I J Clin Med. 2024; 13(17).

PMID: 39274247 PMC: 11396449. DOI: 10.3390/jcm13175034.


Prognostic significance of histologic phenotype in periampullary adenocarcinomas.

Kim H, Heo C, Choi Y, Suh S, Lee S Front Oncol. 2024; 14:1407828.

PMID: 39081711 PMC: 11286735. DOI: 10.3389/fonc.2024.1407828.


Machine learning for differentiating between pancreatobiliary-type and intestinal-type periampullary carcinomas based on CT imaging and clinical findings.

Chen T, Zhang D, Chen S, Lu J, Guo Q, Cai S Abdom Radiol (NY). 2024; 49(3):748-761.

PMID: 38236405 PMC: 10909762. DOI: 10.1007/s00261-023-04151-1.


Impact of circumferential resection margin on survival in ampullary cancer: retrospective analysis.

Niessen A, Loos M, Neumuller K, Feisst M, Klaiber U, Cizmic A BJS Open. 2023; 7(6).

PMID: 38155394 PMC: 10754770. DOI: 10.1093/bjsopen/zrad120.


Ampullary Adenocarcinoma: A Review of the Mutational Landscape and Implications for Treatment.

Tsagkalidis V, Langan R, Ecker B Cancers (Basel). 2023; 15(24).

PMID: 38136318 PMC: 10741460. DOI: 10.3390/cancers15245772.


References
1.
Albores-Saavedra J, Simpson K, Dancer Y, Hruban R . Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas. Ann Diagn Pathol. 2007; 11(1):3-9. DOI: 10.1016/j.anndiagpath.2006.06.008. View

2.
Frierson Jr H . The gross anatomy and histology of the gallbladder, extrahepatic bile ducts, Vaterian system, and minor papilla. Am J Surg Pathol. 1989; 13(2):146-62. DOI: 10.1097/00000478-198902000-00008. View

3.
Bergan A, Gladhaug I, Schjolberg A, Bergan A, Clausen O . p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head. Int J Oncol. 2000; 17(5):921-6. DOI: 10.3892/ijo.17.5.921. View

4.
Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G . Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut. 2005; 54(3):385-7. PMC: 1774412. DOI: 10.1136/gut.2004.047191. View

5.
Yeo C, Sohn T, Cameron J, Hruban R, Lillemoe K, Pitt H . Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998; 227(6):821-31. PMC: 1191384. DOI: 10.1097/00000658-199806000-00005. View